secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001493152-23-022001
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma shareholders elect directors, approve 250K share increase, ratify auditor
--------------------------------------------------------------------------------

- All six director nominees elected: Donald Jeff Keyser, Panna Sharma, Vijay Chandru, Maria Maccecchini, Franklyn Prendergast, David S. Silberstein.
- Amendment to 2018 Equity Incentive Plan approved to increase shares available by 250,000; votes: 4,145,520 For, 96,840 Against, 14,138 Abstain.
- Ratification of EisnerAmper LLP as independent auditor for FY 2023 approved with 7,015,460 For, 41,115 Against, 5,164 Abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223022001/0001493152-23-022001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223022001/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer